0000874716-24-000037.txt : 20240216 0000874716-24-000037.hdr.sgml : 20240216 20240216175606 ACCESSION NUMBER: 0000874716-24-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240214 FILED AS OF DATE: 20240216 DATE AS OF CHANGE: 20240216 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Johnson Michael Perkins CENTRAL INDEX KEY: 0001917747 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19271 FILM NUMBER: 24649855 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE STREET 2: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: IDEXX LABORATORIES INC /DE CENTRAL INDEX KEY: 0000874716 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 010393723 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 BUSINESS PHONE: 2075560300 MAIL ADDRESS: STREET 1: ONE IDEXX DRIVE CITY: WESTBROOK STATE: ME ZIP: 04092-2041 FORMER COMPANY: FORMER CONFORMED NAME: IDEXX CORP / DE DATE OF NAME CHANGE: 19600201 4 1 wk-form4_1708124148.xml FORM 4 X0508 4 2024-02-14 0 0000874716 IDEXX LABORATORIES INC /DE IDXX 0001917747 Johnson Michael Perkins ONE IDEXX DRIVE WESTBROOK ME 04092 0 1 0 0 EVP and CHRO 0 Common Stock 2024-02-14 4 M 0 176 0 A 243.3419 D Common Stock 2024-02-14 4 F 0 60 560.56 D 183.3419 D Non-Qualified Stock Option (right-to-buy) 560.56 2024-02-14 4 A 0 3132 0 A 2034-02-13 Common Stock 3132 3132 D Incentive Stock Option (right-to-buy) 560.56 2024-02-14 4 A 0 178 0 A 2034-02-13 Common Stock 178 178 D Restricted Stock Unit 0 2024-02-14 4 A 0 714 0 A Common Stock 714 714 D Restricted Stock Unit 2024-02-14 4 M 0 176 0 D Common Stock 176 528 D Includes a total of 51.542 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2023, June 30, 2023, September 29, 2023 and December 29, 2023. Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2025. Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2028. Each restricted stock unit ('RSU') represents a contingent right to receive one share of Issuer common stock and vest in four annual installments beginning on February 14, 2025. Each RSU represents a contingent right to receive one share of Issuer common stock. This RSU grant vests in four annual installments, beginning February 14, 2024. /s/ Lily J. Lu, Attorney-in-Fact for Michael P. Johnson 2024-02-16